Southeast Asia Medical Foods Market To Reach $2.1 Billion By 2030

Southeast Asia Medical Foods Market Growth & Trends

The Southeast Asia medical foods market size is expected to reach USD 2.1 billion by 2030 and is projected to expand at 5.1% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The number of elderly patients with critical illnesses has increased significantly in the past few years in the region. The risk of malnutrition and frailty among elderly people with comorbidities such as stroke, depression, and dementia, is much higher mainly owing to various age-related changes in body composition and muscle mass.

This results in a reduced ability to perform Activities of Daily Living (ADLs), thereby increasing the risk of falls or injuries. Therefore, it is important to analyze the pathophysiology behind the condition (nutritional deficiency). This factor is expected to drive the market growth over the estimated period. The growing burden of undernutrition and malnutrition in the form of wasting, stunting, and hidden hunger (due to mineral & vitamin deficiencies) & overweight impedes the survival, growth, and development of children and young people, and thus the overall economies & nations in Southeast Asia.

Most of the stunting occurs in South Asia, which is home to 23% of the world's population. In addition, hidden hunger, in the form of micronutrient deficiencies, affects a large number of children in the region; an estimated 46% of Southeast Asia’s children suffer from at least one micronutrient deficiency. The risks of wasting and stunting among children in Thailand have decelerated economic development in recent years. Child malnutrition in the country is associated with low levels of education, poverty, and poor access to health services.

In December 2019, UNICEF Indonesia announced a partnership with BAPPENAS to launch ‘Complementary Feeding and Maternal Nutrition Frameworks for Action’ in Jakarta. The recommendations covered nutrition and poor diet practices, further limiting the marketing of unhealthy foods products while improving nutrition labeling, and ensuring that healthcare workers have the skills they need to provide nutrition advice to families & mothers.

Some of the risks associated with enteral feeding are blockage, nausea, bleeding, abdominal distention, and infection. Approximately 20% of patients who receive enteral feeding experience nausea & vomiting and about 2-3% of tube-fed patients experience diarrhea. Refeeding syndrome is another risk associated with these devices.

 Request a free sample copy or view report summary: Southeast Asia Medical Foods Market Report

Southeast Asia Medical Foods Market Report Highlights

• The oral route segment dominated the overall market, with a revenue share of 68.5% in 2022. The high share of the segment can be attributed to the huge commercial viability of orally administered products and higher preference for oral medical foods, owing to their ease of consumption & greater storage time

• The powder segment accounted for the largest revenue share of 35.6% in terms of formulation in 2022. This can be attributed to the high preference for powdered formulations and the launch of powdered products by major players

• The adult segment held the largest market share of 94.7% in 2022 and is expected to maintain its dominance over the forecast period, advancing with the fastest CAGR. This can be attributed to the growing awareness regarding medical foods among pregnant women and older adults

• Chemotherapy-induced diarrhea dominated the application market with the largest revenue share of 15.3%. This can be attributed to the rising usage of chemotherapy for the treatment of cancer, owing to the growing prevalence of cancer in the region, and limited access to newer therapies

• In 2022, Indonesia dominated the market with the largest revenue share of 31.00%. The growing prevalence of malnutrition and undernutrition in the country and the rising initiatives to promote the use of medical foods by international authorities are expected to propel the country’s market growth over the forecast period

Southeast Asia Medical Foods Market Segmentation

Grand View Research has segmented the Southeast Asia medical foods market based on the route of administration, product, patient type, application, end-use, sales channel, and region:

Southeast Asia Medical Foods Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)

• Oral

• Enteral

Southeast Asia Medical Foods Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Pills

• Powder

• Liquid

• Others

Southeast Asia Medical Foods Patient Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Adult

• Pediatric

Southeast Asia Medical Foods Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Chronic Kidney Disease

• Minimal Hepatic Encephalopathy

• Chemotherapy-Induced Diarrhea

• Pathogen Related Infections

• Diabetic Neuropathy

• ADHD

• Depression

• Alzheimer's Disease

• Nutritional Deficiency

• Orphan Diseases

  • Tyrosinemia

  • Eosinophilic Esophagitis

  • FPIES

  • Phenylketonuria

  • MSUD

  • Homocystinuria

  • Others

• Wound Healing

• Chronic Diarrhea

• Constipation Relief

• Protein Booster

• Dysphagia

• Pain Management

• Parkinson's Disease

• Epilepsy

• Other Cancer related treatments

• Severe Protein Allergy

• Other

Southeast Asia Medical Foods End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Hospitals

• Nursing Homes

• Homecare

• Others

Southeast Asia Medical Foods Sales Channel Outlook (Revenue, USD Billion, 2018 - 2030)

• Online Sales

• Retail Sales

• Institutional Sales

Southeast Asia Medical Foods Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• Southeast Asia

  • Singapore

  • Indonesia

  • Thailand

  • Malaysia

List of Key Players in the Southeast Asia Medical Foods Market

• Danone S.A.

• Abbott

• Nestlé

• Mead Johnson & Company, LLC

• Fresenius Kabi AG

• Ajinomoto Cambrooke, Inc.

• B. Braun Melsungen AG